PRODUCT

首頁

產品資訊

PRODUCT

首頁

產品資訊

Cambridge 劍橋 CANTAB 測驗 - RTI 反應時間測驗

產品型號: RTI
廠牌名稱: Cambridge Cognition
CANTAB 劍橋認知心理衡鑑系統中的注意力測驗之一

產品特點

  • 簡介:反應時間 (RTI) 是一個具有五個選項的延遲性的作業,且其所使用的程序可以區分出反應性延遲 (反應速度) 和移動的時間。其較 CRT 與 SRT 測驗實用之處為受測者需要控制可能的震顫。
  • 施測時間:大約 5 分鐘,視其損傷的程度而定。
  • 作業:本作業可分為五個階段,需要逐步增加反應鏈的複雜度。在每個測試裡面,受測者都需要在黃點出現的時候盡快地做出反應。在某些階段,黃點可能會出現在五個位置中之一,受測者有時候可能會用到反應鍵盤盒、有時候需要觸碰螢幕,有時候兩者都需要使用。
  • 測驗結果:RTI 的四個測量結果可以分成反應時間 (簡單反應時間和五選項反應時間) 以及移動時間 (簡單移動時間和五選項移動時間)。

CANTAB Connect Research 劍橋神經認知測驗介紹

產品規格

主要參考文獻

CANTAB Alzheimer’s (Dementia) Battery
• Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. Paired associate performance in the early detection of DAT. Journal of the International Neuropsychological Society : JINS. 2002;8(1):58-71.
• Egerhazi A, Berecz R, Bartok E, Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer’s disease. Progress in neuro-psychopharmacology & biological psychiatry. 2007;31(3):746-51. Epub 2007/02/10.
• Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer’s disease. Dement Geriatr Cogn Disord. 2004;17(1-2):42-8. Epub 2003 Oct 13.
• Greig NH, Sambamurti K, Yu QS, Brossi A, Bruinsma GB, Lahiri DK. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. Curr Alzheimer Res. 2005;2(3):281-90.
• Atack JR. Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA. Pharmacology & therapeutics. 2010;125(1):11-26. Epub 2009/09/23.
- 更多資訊請見: http://www.cambridgecognition.com/academic-studies/product/cantab-dementia-battery#sthash.rL7KE7eu.dpuf

CANTAB Schizophrenia Battery
• Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD. Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev. 2010 Jul;34(8):1161-77. doi: 10.1016/j.neubiorev.2010.01.012. Epub 2010 Jan 25.
• Joyce E, Hutton S, Mutsatsa S, Gibbins H, Webb E, Paul S, Robbins T, Barnes T. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry Suppl. 2002 Sep;43:s38-44.
• Saleem MM, Harte MK, Marshall KM, Scally A, Brewin A, Neill JC. First episode psychosis patients show impaired cognitive function--a study of a South Asian population in the UK. J Psychopharmacol. 2013 Apr;27(4):366-73. Epub 2013 Feb 20.
• Zhornitsky S, Aubin G, Desfossés J, Rizkallah E, Pampoulova T, Lipp O, Chiasson JP, Stip E, Potvin S. Predictors of community functioning in schizophrenia and substance use disorder patients. Community Ment Health J. 2013 Jun;49(3):317-22. Epub 2012 Jul 31.
• Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, Fennig S, Treves I, Kron S. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry. 2010 Feb;71(2):138-49. Epub 2009 Nov 3.
- 更多資訊請見:http://www.cambridgecognition.com/academic-studies/product/cantab-schizophrenia-battery#sthash.OMAEK5Un.dpuf

應用領域

用於:CANTAB Alzheimer’s battery 和 CANTAB schizophrenia battery

詢價表單

填寫完成

您可以繼續瀏覽或轉移至產品列表!

回產品列表